Welcome to our dedicated page for ALCHEMY INVTS ACQUISITN 1 SEC filings (Ticker: ALCY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Access SEC filings for Alchemy Investments Acquisition Corp 1 (ALCY), a Special Purpose Acquisition Company. SPAC filings focus on the search for acquisition targets, merger negotiations, and the eventual business combination process that transforms the shell company into an operating entity.
Key filings for SPACs include 8-K forms announcing material events such as definitive merger agreements, extension votes, and business combination closings. The 10-K annual report and 10-Q quarterly reports detail the trust account balance, management fees, and timeline constraints. Proxy statements (DEF 14A) provide crucial information when shareholders vote on proposed business combinations, including transaction terms, valuation details, and redemption procedures.
Understanding SPAC filings requires attention to specific disclosures: the remaining time before the company must complete a merger or liquidate, the per-share trust account value available for redemption, and the terms of any proposed business combination. Form 4 filings track insider transactions, showing when management or sponsors purchase or sell shares, which can signal confidence in proposed deals.
Alchemy Investments Acquisition Corp 1 (ALCY), a SPAC, reported a net loss of $341,897 for the quarter and $863,650 for the nine months ended September 30, 2025, compared with strong gains a year earlier driven by trust investment income. Operating and formation costs rose to $1.15 million for the nine-month period, while income from investments in the trust account dropped sharply.
At September 30, 2025, ALCY held $8.66 million of investments in its trust account and $319,258 of cash outside the trust, but faced a working capital deficit of about $3.0 million and a shareholders’ deficit of $8.1 million. Management disclosed substantial doubt about its ability to continue as a going concern, noting reliance on completing a business combination.
ALCY has signed a $540 million Business Combination Agreement with Cartiga, LLC, using an Up‑C structure with a new Delaware “Pubco” that will be renamed Cartiga Holdings, Inc. The deal requires, among other conditions, shareholder approvals, Nasdaq listing of the combined company, and at least $40 million of available closing cash, with sponsor share forfeitures possible if this cash condition is waived.
Alchemy Investments Acquisition Corp. 1 furnished an investor presentation related to its proposed business combination with Cartiga, LLC. The presentation, dated October 2025, was provided under Item 7.01 (Reg FD) and attached as Exhibit 99.1; it is not deemed “filed” for liability purposes.
The company plans to submit a Form S-4 with a preliminary proxy statement/prospectus, followed by a definitive proxy statement and final prospectus for a shareholder vote at a Special Meeting. The filing includes standard forward‑looking statements and notes that directors and officers of both parties may be deemed participants in the proxy solicitation.
Alchemy Investments Acquisition Corp. 1 furnished an investor presentation related to its proposed business combination with Cartiga, LLC. The presentation, dated October 2025, was provided under Item 7.01 (Regulation FD) and is attached as Exhibit 99.1. The materials are described as furnished, not filed.
The company plans to submit a Form S-4 with a preliminary proxy statement/prospectus and, when available, will mail a definitive proxy statement and proxy card to shareholders. Documents will be accessible via www.sec.gov. The company’s securities trade on Nasdaq as ALCYU (units), ALCY (Class A ordinary shares), and ALCYW (warrants).
FAQ
What is the current stock price of ALCHEMY INVTS ACQUISITN 1 (ALCY)?
What is the market cap of ALCHEMY INVTS ACQUISITN 1 (ALCY)?
